Why Chima Came Up Short in Nuclear Exports

Why It Matters

China’s export shortfall curtails its strategic influence on the global nuclear supply chain, while Russia’s aggressive model reshapes market leadership and financing norms for developing nations.

Key Takeaways

• China built three Hualong One reactors, all in Pakistan
• No CAP1400 export contracts secured to date
• Rosatom leads with eight VVERs under construction abroad
• Financing, geopolitics, and US controls hinder Chinese exports
• Large reactor sizes misfit developing nations’ grids

Pulse Analysis

China’s nuclear programme is a cornerstone of its energy strategy, boasting 60 operating reactors and dozens more under construction. The government has packaged its flagship designs—the 1,100 MW Hualong One and the larger 1,400 MW CAP1400—into the Belt and Road "Nuclear Silk Road" to win export contracts. Early successes were limited to Pakistan, where three Hualong One units were financed almost entirely by Chinese loans, but attempts in Argentina, the United Kingdom and Turkey have faltered amid financing disputes, security concerns, and shifting political priorities.

Russia’s state‑run Rosatom illustrates a contrasting approach that has resonated with emerging markets. By offering a full Build‑Own‑Operate package, including financing, construction, fuel supply and spent‑fuel management, Rosatom reduces the capital burden and technical risk for client nations. This model has secured eight 1,200 MW VVER projects across Turkey, Egypt, Bangladesh and India, and is backed by long‑term fuel agreements that lock in Russian influence. The comprehensive service package, combined with flexible financing, gives Russia a decisive edge over China’s more fragmented export strategy.

Several systemic barriers impede China’s export ambitions. High upfront costs, amplified by the need to import Chinese engineers and manage long supply chains, deter cash‑strapped developing economies. The CAP1400’s large footprint clashes with the limited grid capacity of many target markets, while U.S. export‑control rules on technology derived from the AP1000 add regulatory complexity. Moreover, geopolitical scrutiny—especially in Western democracies—restricts Chinese participation in sensitive infrastructure projects. As the industry pivots toward smaller, cost‑effective SMRs, China may need to recalibrate its export portfolio to remain competitive in the evolving global nuclear market.